Thrombotic Microangiopathy Due to Malignant Hypertension Treated Exclusively With Antihypertensive Therapy

Plasma exchange is the commonly considered therapy for the treatment of thrombotic microangiopathy (TMA); however, it is not always mandatory. We treated a patient who presented with malignant hypertension (MH) complicated by TMA using antihypertensive therapy that was not accompanied by plasma exch...

Descripción completa

Detalles Bibliográficos
Autores principales: Asano, Taro, Mori, Hideki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895853/
https://www.ncbi.nlm.nih.gov/pubmed/35291517
http://dx.doi.org/10.7759/cureus.21835

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895853/
https://www.ncbi.nlm.nih.gov/pubmed/35291517
http://dx.doi.org/10.7759/cureus.21835

Ejemplares similares